Patent 7998677 was granted and assigned to Regulus Therapeutics on August, 2011 by the United States Patent and Trademark Office.
Provided herein are methods for detection of miRNA in a sample. In certain embodiments, the sample comprises RNA and is derived from a cell or tissue. The methods of detection employ a competitor molecule to allow for detection of an miRNA in the presence of an anti-miRNA oligonucleotide.